Investors

Invus is a venture capital fund managing over $8 billion, with offices in New York, Paris, Singapore, and Hong Kong. They specialize in biotech and health tech, investing in later stages of company growth. Notable investments include Achilles Therapeutics and Sensorion. Their evergreen structure allows for a long-term investment horizon, supporting sustained growth and development in transformative healthcare businesses.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Recent Investments